Journal article
Lack of Effectiveness of Tissue Plasminogen Activator 20 or More Days After Vitrectomy
Archives of ophthalmology (1960), Vol.109(5), pp.614-614
05/01/1991
DOI: 10.1001/archopht.1991.01080050020010
PMID: 1902660
Abstract
Tissue plasminogen activator (TPA) causes the resolution of intraocular fibrin after vitrectomy, even at the low dose of 6 μg.1 Experiments show, however, that it can increase the risk of intraocular bleeding, especially if used soon after surgery.2 It may be better to wait as long as possible after surgery before using TPA. We report two cases in which TPA was ineffective in resolving intraocular fibrin when administered 20 days or more after a vitrectomy.
Details
- Title: Subtitle
- Lack of Effectiveness of Tissue Plasminogen Activator 20 or More Days After Vitrectomy
- Creators
- James C FolkJonathan M HersheyMichael B Rivers
- Resource Type
- Journal article
- Publication Details
- Archives of ophthalmology (1960), Vol.109(5), pp.614-614
- DOI
- 10.1001/archopht.1991.01080050020010
- PMID
- 1902660
- NLM abbreviation
- Arch Ophthalmol
- ISSN
- 0003-9950
- eISSN
- 1538-3601
- Publisher
- American Medical Association
- Language
- English
- Date published
- 05/01/1991
- Academic Unit
- Ophthalmology and Visual Sciences
- Record Identifier
- 9983980034402771
Metrics
18 Record Views